Prognosis in patients with serous and mucinous stage i borderline ovarian tumors

International Journal of Gynecological Cancer

Volumn 22, Issue 5, 2012, Pages 770-777

  Song, Taejong ^a   Lee, Yoo Young ^b   Choi, Chel Hun ^b   Kim, Tae Joong ^b   Lee, Jeong Won ^b   Kim, Byoung Gie ^b   Bae, Duk Soo ^b  

^a CHA University   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Borderline ovarian tumor; Mucinous tumor; Serous tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN;

ABDOMINAL HYSTERECTOMY; ADJUVANT THERAPY; ADOLESCENT; ADULT; APPENDECTOMY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MUCINOUS STAGE I BORDERLINE OVARIAN TUMOR; OVARY TUMOR; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; SEROUS STAGE I BORDERLINE OVARIAN TUMOR; TUMOR RECURRENCE; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; ADULT; CA-125 ANTIGEN; CYSTADENOCARCINOMA, SEROUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84863662585     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31824b4076     Document Type: Article

References (24)

1. Seidman JD, Russell P, Kurman RJ. Surface epithelial tumors of the ovary. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York, NY: Springer-Verlag; 2002:791-904.
2. Scully RE. World Health Organization International Histological Classification of Tumours. 2nd ed. New York, NY: Springer; 1999.
3. Yoon A, Kim TJ, Lee WS, et al. Single-port access laparoscopic staging operation for a borderline ovarian tumor. J Gynecol Oncol. 2011;22:127-130.
4. Cadron I, Amant F, Van Gorp T, et al. The management of borderline tumours of the ovary. Curr Opin Oncol. 2006;18:488-493. (Pubitemid 44199846)
5. Koskas M, Uzan C, Gouy S, et al. Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma). Ann Surg Oncol. 2011;18:40-48.
6. Benito V, Lubrano A, Arencibia O, et al. Serous and mucinous borderline ovarian tumors: are there real differences between these two entities? Eur J Obstet Gynecol Reprod Biol. 2010;153:188-192.
7. Zanetta G, Rota S, Chiari S, et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol. 2001;19:2658-2664. (Pubitemid 32441370)
8. Song T, Choi CH, Kim HJ, et al. Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors. Eur J Obstet Gynecol Reprod Biol. 2011;156:204-208.
9. Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer. 1973;31:1031-1045.
10. Bell DA. Ovarian surface epithelial-stromal tumors. Hum Pathol. 1991;22:750-762.
11. Ronnett BM, Kajdacsy-Balla A, Gilks CB, et al. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol. 2004;35:949-960. (Pubitemid 39037178)
12. Khunamornpong S, Settakorn J, Sukpan K, et al. Mucinous tumor of low malignant potential ("borderline" or "atypical proliferative" tumor) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion. Int J Gynecol Pathol. 2011;30:218-230.
13. Lee KR, Scully RE. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'. Am J Surg Pathol. 2000;24:1447-1464.
14. Cadron I, Leunen K, Van Gorp T, et al. Management of borderline ovarian neoplasms. J Clin Oncol. 2007;25:2928-2937. (Pubitemid 47123157)
15. Morice P. Borderline tumours of the ovary and fertility. Eur J Cancer. 2006;42:149-158. (Pubitemid 43083483)
16. Camatte S, Morice P, Thoury A, et al. Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer. 2004;40:1842-1849. (Pubitemid 39036758)
17. Shih KK, Zhou Q, Huh J, et al. Risk factors for recurrence of ovarian borderline tumors. Gynecol Oncol. 2011;120:480-484.
18. Park JY, Kim DY, Kim JH, et al. Surgical management of borderline ovarian tumors: the role of fertility-sparing surgery. Gynecol Oncol. 2009;113:75-82.
19. Wong HF, Low JJ, Chua Y, et al. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer. 2007;17:342-349. (Pubitemid 46426778)
20. Nomura K, Aizawa S, Hano H. Ovarian mucinous borderline tumors of intestinal type without intraepithelial carcinoma: are they still tumors of low malignant potential? Pathol Int. 2004;54:420-424. (Pubitemid 38829928)
21. Vang R, Gown AM, Zhao C, et al. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am J Surg Pathol. 2007;31:854-869. (Pubitemid 47165138)
22. Kolwijck E, Thomas CM, Bulten J, et al. Preoperative CA-125 levels in 123 patients with borderline ovarian tumors: a retrospective analysis and review of the literature. Int J Gynecol Cancer. 2009;19:1335-1338.
23. Engelen MJ, de Bruijn HW, Hollema H, et al. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors. Gynecol Oncol. 2000;78:16-20. (Pubitemid 30439472)
24. Crispens MA, Bodurka D, Deavers M, et al. Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. Obstet Gynecol. 2002;99:3-10. (Pubitemid 34075460)